BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25284854)

  • 1. The First Report of KRT5 Mutation Underlying Acantholytic Dowling-Degos Disease with Mottled Hypopigmentation in an Indian Family.
    Verma S; Pasternack SM; Rütten A; Ruzicka T; Betz RC; Hanneken S
    Indian J Dermatol; 2014 Sep; 59(5):476-80. PubMed ID: 25284854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dowling-Degos Disease in the Anogenital Region.
    Belamarić M; Ljubojević Hadžavdić S
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):261-262. PubMed ID: 36919394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galli-Galli Disease Presenting as a Lentigo-like Eruption: A Further Clinical Feature in the Wide Spectrum of Reticulate Pigment Disorders.
    Paolino G; Donati M; Didona D; Panetta C; Donati P
    Acta Dermatovenerol Croat; 2017 Dec; 25(4):300-302. PubMed ID: 30064605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous frameshift mutation in keratin 5 in a family with Galli-Galli disease.
    Reisenauer AK; Wordingham SV; York J; Kokkonen EW; Mclean WH; Wilson NJ; Smith FJ
    Br J Dermatol; 2014 Jun; 170(6):1362-5. PubMed ID: 24372084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel heterozygous nonsense mutation of keratin 5 in a Chinese family with Dowling-Degos disease.
    Guo L; Luo X; Zhao A; Huang H; Wei Z; Chen L; Qin S; Shao L; Xuan J; Feng G; Minghua C; Luan J; He L; Xing Q
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):908-10. PubMed ID: 21569119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis Suppurativa Associated with Galli-Galli Disease: Extending the Link with Dowling-Degos Disease.
    Del Mar M; González M; Sayed C; Phadke P
    J Clin Aesthet Dermatol; 2020 Dec; 13(12):38-40. PubMed ID: 33488918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expanding spectrum of Galli-Galli disease.
    El Shabrawi-Caelen L; Rütten A; Kerl H
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S86-91. PubMed ID: 17434047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galli-Galli Disease: A Comprehensive Literature Review.
    Michelerio A; Greco A; Tomasini D; Tomasini C
    Dermatopathology (Basel); 2024 Feb; 11(1):79-100. PubMed ID: 38390850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease.
    Hanneken S; Rütten A; Pasternack SM; Eigelshoven S; El Shabrawi-Caelen L; Wenzel J; Braun-Falco M; Ruzicka T; Nöthen MM; Kruse R; Betz RC
    Br J Dermatol; 2010 Jul; 163(1):197-200. PubMed ID: 20222933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of reticulate acropigmentation of kitamura: dowling degos disease overlap with unusual clinical manifestations.
    Vasudevan B; Verma R; Badwal S; Pragasam V; Moorchung N; Badad A
    Indian J Dermatol; 2014 May; 59(3):290-2. PubMed ID: 24891663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized Dowling-Degos disease.
    Wu YH; Lin YC
    J Am Acad Dermatol; 2007 Aug; 57(2):327-34. PubMed ID: 17637446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Disseminated Variant of Galli-Galli Disease: A Review of the Literature.
    Yang A; Cheung K; Kossard S; Murrell DF
    Am J Dermatopathol; 2020 Jul; 42(7):484-490. PubMed ID: 31449063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease?
    Braun-Falco M; Volgger W; Borelli S; Ring J; Disch R
    J Am Acad Dermatol; 2001 Nov; 45(5):760-3. PubMed ID: 11606930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galli-Galli disease: A case report with review of the literature.
    Gilchrist H; Jackson S; Morse L; Nicotri T; Nesbitt LT
    J Am Acad Dermatol; 2008 Feb; 58(2):299-302. PubMed ID: 18222327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbation of Galli-Galli Disease Following Dialysis Treatment: A Case Report and Review of Aggravating Factors.
    Joshi TP; Shaver S; Tschen J
    Cureus; 2021 Jun; 13(6):e15401. PubMed ID: 34249550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galli-galli disease: a rare acantholytic variant of dowling-degos disease.
    Gomes J; Labareda J; Viana I
    Case Rep Med; 2011; 2011():703257. PubMed ID: 21629813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-existence of leukoderma with features of Dowling-Degos disease: reticulate acropigmentation of Kitamura spectrum in five unrelated patients.
    Lestringant GG; Masouyé I; Frossard PM; Adeghate E; Galadari IH
    Dermatology; 1997; 195(4):337-43. PubMed ID: 9529553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acitretin therapy for Galli-Galli disease.
    Rundle CW; Ophaug S; Simpson EL
    JAAD Case Rep; 2020 May; 6(5):457-461. PubMed ID: 32382646
    [No Abstract]   [Full Text] [Related]  

  • 19. Coexistence of reticulate acropigmentation of Kitamura and Dowling-Degos disease.
    Cabral AR; Santiago F; Reis JP
    Dermatol Reports; 2011 Aug; 3(2):e33. PubMed ID: 25386285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Galli-Galli disease. Clinical and histopathological investigation using a case series of 18 patients].
    Hanneken S; Rütten A; Eigelshoven S; Braun-Falco M; Pasternack SM; Ruzicka T; Nöthen MM; Betz RC; Kruse R
    Hautarzt; 2011 Nov; 62(11):842-51. PubMed ID: 21971768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.